Xin Luan

19PUBLICATIONS
40CO-AUTHORS
Cancer cell biologyMolecular targetsProteins and peptidesApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Gene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (19)

|Sep 02, 2026
Targeting CTGF+ cancer-associated fibroblasts disrupts tumor-stroma crosstalk in pancreatic ductal adenocarcinoma.

|Aug 26, 2026
RIBOTAC-mediated degradation of hsa-microRNA-301a-3p suppresses TNBC bone metastasis.

|Jun 08, 2026
Progress in Natural Products Target Discovery Technology.

|May 12, 2026
Mechanism-Informed Machine Learning Enables Discovery of Oncolytic Peptides for Cancer Immunotherapy.

|Nov 28, 2025
IFN-γ-driven UBE2D3 upregulation impairs antigen presentation pathways and anti-tumor immunity in pancreatic cancer.

Shiqun Wang, Wenyan Yang, Ti Peng

|Jul 18, 2025
Immuno-Initiator Rectifies Immunodeficiency to Restore Immune Function and Potentiate Immunotherapy against IDH Mutant Glioma.

Songlei Zhou, Fenfen Ma, Jianing Gong

Pageof 4

Frequent Collaborators

3 joint publications

Jinmei Jin

3 joint publications

Weidong Zhang

2 joint publications

Li-Jun Zhang

2 joint publications

Hongzhuan Chen